NBTX · Nanobiotix S.A.
$42.26
+3.95 (+10.30%)
At close · Aug 17
Market Cap
$1.95B
Shares
50.80M
Nanobiotix S.A. Earnings Call Transcripts
Every quarterly earnings call for Nanobiotix S.A. (NBTX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q4
2025-12-31
Nanobiotix S.A. Q4 FY2025 Earnings Call
Positive tone
MD Anderson ISTs and data generation
NBTXR3/J&J collaboration and pipeline
Unresectable stage 3 lung cancer (J&J Converge trial)
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q1
2024-03-31
Nanobiotix S.A. Q1 FY2024 Earnings Call
Positive tone
Janssen/J&J Collaboration and NANORAY-312 Pivotal Trial
Immuno-Oncology Combination and ASCO Presentation
Pipeline Expansion: Curadigm and Oocuity Platforms
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Nanobiotix S.A. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Nanobiotix S.A. Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Nanobiotix S.A. Q2 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1760854
CUSIP
63009J107
13F (30d)
20 filings
20 filers
Visit website
Investor relations